Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5495-5499

  Garrido, Carmen ^a   Fromentin, Annie ^a   Bonnotte, Bernard ^a   Favre, Nathalie ^a   Moutet, Monique ^a   Arrigo, André Patrick ^b   Mehlen, Patrick ^b   Solary, Eric ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CISPLATIN; DOXORUBICIN; HEAT SHOCK PROTEIN 27;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL CLONE; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL DEATH; CLONE CELLS; COLONIC NEOPLASMS; HEAT-SHOCK PROTEINS; MICE; MICE, NUDE; RATS; RATS, INBRED STRAINS; TUMOR CELLS, CULTURED;

EID: 0032404094     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Martin, F., Caignard, A., Jeannin, J. F., Leclerc, A., and Martin, M. Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int. J. Cancer, 32: 623-628, 1983.
2. Caignard, A., Martin, M. S., Michel, M. S., and Martin, F. Interaction between two cellular subpopulations of rat colonic carcinoma when inoculated to the syngeneic host. Int. J. Cancer, 36: 373-377, 1985.
3. Shimizu, T., Martin, M. S., Pelletier, H., Lagadec, P., and Martin, F. Effects of cyclosporin A on progressive and regressive tumors induced by two cancer lines derived from a single colon carcinoma chemically induced in the rat. Immunobiology, 178: 401-407, 1989.
4. Caignard, A., Pelletier, H., and Martin, F. Specificity of the immune response leading to protection or enhancement by regressive and progressive variants of a rat colon carcinoma. Int. J. Cancer, 42: 883-889, 1988.
5. Bonnette, B., Favre, N., Moutet, M., Fromentin, A., Solary, E., Martin, M., and Martin, F. Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors. J. Immunol., 161: 1433-1438, 1998.
6. Hording, C. V., and Song, R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol., 153: 4925-4930, 1994.
7. Falo, L. D., Kovacsovics-Bankowski, M., Thompson, K., and Rock, K. L. Targeting antigen into the phagocytic pathway in vivo induces protective tumor immunity. Nat. Med., 1: 649-653, 1995.
8. Bonnotte, B., Favre, N., Reveneau, S., Micheau, O., Droin, N., Garrido, C., Fontana, A., Chauffert, B., Solary, E., and Martin, F. Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate. Cell Death Differ., 5: 480-487, 1998.
9. Parsell, D. A., and Lindquist, S. Heat shock proteins and stress tolerance. In: R. I. Morimoto, A. Tissières, and C. Georgopoulos (eds.), The Biology of Heat Shock Proteins and Molecular Chaperones, pp. 457-494. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1990.
10. Arrigo, A. P., and Landry, J. Expression and function of the low molecular weight heat shock proteins. In: R. I. Morimoto, A. Tissières, and C. Georgopoulos (eds), Heat Shock Proteins: Structure, Function and Regulation, pp. 335-373. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1994.
11. Ehrnsperger, M., Graber, S., Gaestel, M., and Buchner, J. Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J., 16: 221-229, 1997.
12. Huot, J., Houle, F., Spitz, D. R., and Landry, J. HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res., 56: 273-279, 1996.
13. Mehlen, P., Kretz-Remy, C., Preville, X., and Arrigo, A. P. Human hsp27, Drosophila hsp27 and αβ-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFα-induced cell death. EMBO J., 15: 2695-2706, 1996.
14. Landry, J., Chrétien, P., Lambert, H., Hickey, E., and Weber, L. A. Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J. Cell Biol., 109: 7-15, 1989.
15. r 27,000 heat shock protein. Cancer Res., 51: 5245-5252, 1991.
16. Mehlen, P., Briolay, J., Smith, L., Diaz-Latoud, C., Fabre, N., Pauli, D., and Arrigo, A. P. Analysis of the resistance to heat and hydrogen peroxide stresses in COS cells transiently expressing wild type or deletion mutants of the Drosophila 27-kDa heat shock protein. Eur. J. Biochem., 215: 277-284, 1993.
17. Oesterreich, S., Weng, C. N., Qiu, M., Hilsenbeck, S. G., Osborne, C. K., and Fuqua, S. W. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res., 53: 4443-4448, 1993.
18. Garrido, C., Mehlen, P., Fromentin, A., Hamman, A., Assem, M., Arrigo, A. P., and Chauffert, B. Inconstant association between hsp27 content and doxorubicin resistance in human colon cancer cells. Eur. J. Biochem., 237: 653-659, 1996.
19. Garrido, C., Ottavi, P., Fromentin, A., Hamman, A., Arrigo, A. P., Chauffert, B., and Mehlen, P. Hsp27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res., 57: 2661-2667, 1997.
20. Mehlen, P., Preville, X., Chareyron, P., Briolay, J., Klemenz, R., and Arrigo, A. P. Constitutive expression of human hsp27, Drosophila hsp27, or human αβ crystallin confers resistance to TNF-and oxidative stress-induced cytotoxicity in stably transfected murine L929 fibroblasts. J. Immunol., 215: 363-374, 1995.
21. Mehlen, P., Schulze-Osthoff, K., and Arrigo, A. P. Small stress proteins as novel regulators of apoptosis. J. Biol. Chem., 271: 16510-16514, 1996.
22. Rösl, F. A rapid and simple method for detection of apoptosis in human cells. Nucleic Acids Res., 20: 5243-5247, 1992.
23. r 27,000 heat shock protein (hsp27). Cell Growth Differ., 7: 1167-1174, 1996.
24. Knauf, U., Bielka, H., and Gaestel, M. Over-expression of the small heat-shock protein, hsp25, inhibits growth of Ehrlich ascites tumor cells. FEBS Lett., 3: 297-302, 1992.
25. Mehlen, P., Mehlen, A., Godet, J., and Arrigo, A. P. Hsp27 as a switch between differentiation and apoptosis in murine embryonic stem cells. J. Biol. Chem., 272: 31641-31653, 1997.
26. Samali, A., and Cotter, T. G. Heat shock proteins increase resistance to apoptosis. Exp. Cell Res., 223: 163-170, 1996.
27. Têtu, F., Lacasse, B., Bouchard, H. L., Lagacé, R., Huot, J., and Landry, J. Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study. Cancer Res., 52: 2325-2328, 1992.
28. Strahler, J. R., Kuick, R., Eckerskom, C., Lottspeich, F., Richardson, B. C., Fox, D. A., Stoolman, L. M., Hanson, C. A., Nichols, D., Tueche, H. J., and Hanash, S. M. Identification of two related markers for common acute lymphoblastic leukemia as heat shock protein. J. Clin. Investig., 85: 200-207, 1990.
29. Ungar, D., Hailat, N., Strahler, J., Kuick, R., Broudeur, G., Seeger, R., Reynolds, C., and Hanash, S. Hsp27 expression in neuroblastoma: correlation with disease stage. J. Natl. Cancer Inst., 86: 780-784, 1994.
30. Harrison, J. D., Jones, J. A., and Ellis, I. O. Oestrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer. Br. J. Surg., 78: 334-336, 1991.
31. Ciocca, D. R., and Luque, E. H. Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer. Breast Cancer Res. Treat., 20: 33-42, 1991.
32. Thor, A., Benz, C., Moore, D., Goldman, E., Edgerton, S., Landry, J., Schwartz, L., Mayall, B., Hickey, E., and Weber, L. A. Stress response protein (hsp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J. Natl. Cancer Inst., 83: 170-178, 1991.
33. Love, S., and King, R. J. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br. J. Cancer, 69: 743-748, 1994.
34. Blackburn, R., Galoforo, S. S., Berns, C. M., Armour, E. P., McEachern, D., Corry, P. M., and Lee, Y. J. Comparison of tumor growth between HSP25 and HSP27 transfected murine L929 cells in nude mice. Int. J. Cancer, 72: 871-877, 1997.
35. Nagata, S., and Golstein, P. The Fas death factor. Science (Washington DC), 267: 1449-1456, 1995.